The role of fractalkine in the development of diabetic macular edema in patients with type 2 diabetes mellitus
Journal Title: Міжнародний ендокринологічний журнал - Year 2019, Vol 15, Issue 1
Abstract
Background. Diabetic macular edema (DME) is a severe complication of type 2 diabetes mellitus (DM) and a leading cause of vision loss in the working age population of most developed countries. The gold standard for DME treatment should be based on a good control of glycemia along with control of lipids and renal function. However, despite the systemic metabolic control values being essential for patients with diabetic retinopathy, it has proven to be insufficient for DME if it appears. In these patients, additional measures are needed in order to avoid the subsequent loss of vision. The aim of the work was to assess the content of blood fractalkine in patients with type 2 DM and DME in conjunction with the indicators of the thickness of the macula layers. Materials and methods. The study involved 82 patients with type 2 DM (145 eyes), divided into 4 groups in accordance with the DME form. The average age of patients was 65.25 ± 10.85 years, the average duration of DM — 14.00 ± 7.05 years, the average level of HbA1c — 8.40 ± 1.58 %. Results. Using analysis of variance and regression analysis, methods for constructing logistic regression models, we have shown that fractalkine is not associated with the risk of not low values (> QI) of nerve fiber layer, ganglion cell layer, inner plexiform layer, central sector of macula, thickness of fovea. Conclusions. Fractalkine may be a promising new therapeutic method for the treatment of diabetic retinal diseases. DME tends to be a chronic disease, although spontaneous recovery is not uncommon. It is important to recognize that 35 % of patients with macular edema had spontaneous resolution after 6 months if untreated.
Authors and Affiliations
M. L. Kyryliuk, S. А. Suk, S. O. Rykov, S. Yu. Mogilevskyy
Keywords
Related Articles
- EP ID EP535819
- DOI 10.22141/2224-0721.15.1.2019.158686
- Views 73
- Downloads 0
Features of Menstrual Disorders in Obese Women and Ways for Their Correction Using Orlistat
The research deals with the problem of reproductive health in women with obesity. In obese women, oligomenorrhea (in 62.2 % of examines patients) prevails in the structure of menstrual disorders. On the background of obe...
Features of the Course and Control of Bronchial Asthma among Schoolchildren with Overweight
The study of clinical features and identification of inflammatory markers in the bronchi of 52 schoolchildren with overweight and bronchial asthma has been carried out. It was found that overweight children are character...
The Prediction of Type 1 Diabetes Development and Diagnosis of Its Asymptomatic Phase Using Autoantibodies to Human Islets of Langerhans Long Before the Onset of the Disease
The article deals with an analysis of the latest data of world literature and the results of own twenty-year researches on studying antibodies to human islets of Langerhans, and their use as a test for predicting the ris...
Reproductive Function Disorders in Women with Thyroid Dysfunction (Review of the Problem)
The article provides the information on the prevalence in the population and the impact on female reproductive function of diseases associated with thyroid hypofunction. The authors analyzed the literature on this issue....
Insulin Toujeo® — a Novel Basal Long-Acting Insulin Formulation Part 1. Pharmacokinetic and Pharmacodynamic Aspects
This review, consisting of two parts, considers a new formulation of insulin glargine (rDNA origin) in the form of injections 300 U/ml (Gla-300, Toujeo®). Gla-300 is a next generation basal insulin with a novel formulati...